UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Striae distensae (stretch marks)

Authors
Jennifer L MacGregor, MD
Naissan O Wesley, MD
Section Editor
Jeffrey S Dover, MD, FRCPC
Deputy Editor
Abena O Ofori, MD

INTRODUCTION

Striae distensae are a common form of dermal scarring that appear on the skin as erythematous, violaceous, or hypopigmented linear striations. Synonyms include the terms striae, stretch marks, and striae atrophicans. Striae gravidarum are striae distensae occurring secondary to pregnancy.

There are two main types of striae distensae, striae rubra and striae alba. Striae rubra are the earliest presentation of striae distensae and are characterized by an erythematous to violaceous color (picture 1A-C). Over time, striae rubra evolve into striae alba, which appear hypopigmented, atrophic, and scar-like (picture 2A-B). Common locations for striae distensae are the abdomen, breasts, medial upper arms, hips, lower back, buttocks, and thighs.

Although typically asymptomatic, striae distensae may be disfiguring and psychologically distressing to patients. Various topical and procedural modalities have been employed for the treatment of striae distensae. (See 'Treatment' below and 'Prevention' below.)

The clinical features, diagnosis, and management of striae distensae will be reviewed here.

EPIDEMIOLOGY AND RISK FACTORS

Epidemiologic data on striae distensae in the general population are limited [1-11]. Reported incidences have ranged from as low as 11 percent in normal men to up to 88 percent in pregnant females [5,11]. Predisposing factors include pregnancy, adolescent age, drug exposure (eg, topical or systemic corticosteroids), underlying disease (eg, Cushing's syndrome), and surgery (eg, breast augmentation) [12,13]. A more extensive list of associated conditions is provided (table 1).

                      
To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:

Subscribers log in here

Literature review current through: Oct 2017. | This topic last updated: Dec 29, 2015.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. Cho S, Park ES, Lee DH, et al. Clinical features and risk factors for striae distensae in Korean adolescents. J Eur Acad Dermatol Venereol 2006; 20:1108.
  2. SISSON WR. Colored striae in adolescent children. J Pediatr 1954; 45:520.
  3. Chang AL, Agredano YZ, Kimball AB. Risk factors associated with striae gravidarum. J Am Acad Dermatol 2004; 51:881.
  4. Thomas RG, Liston WA. Clinical associations of striae gravidarum. J Obstet Gynaecol 2004; 24:270.
  5. Ghasemi A, Gorouhi F, Rashighi-Firoozabadi M, et al. Striae gravidarum: associated factors. J Eur Acad Dermatol Venereol 2007; 21:743.
  6. Osman H, Rubeiz N, Tamim H, Nassar AH. Risk factors for the development of striae gravidarum. Am J Obstet Gynecol 2007; 196:62.e1.
  7. Davey CM. Factors associated with the occurrence of striae gravidarum. J Obstet Gynaecol Br Commonw 1972; 79:1113.
  8. García-Hidalgo L, Orozco-Topete R, Gonzalez-Barranco J, et al. Dermatoses in 156 obese adults. Obes Res 1999; 7:299.
  9. García Hidalgo L. Dermatological complications of obesity. Am J Clin Dermatol 2002; 3:497.
  10. Sybert VP. Striae in adolescent males. Pediatr Dermatol 2010; 27:576.
  11. Elton RF, Pinkus H. Striae in normal men. Arch Dermatol 1966; 94:33.
  12. Basile FV, Basile AV, Basile AR. Striae distensae after breast augmentation. Aesthetic Plast Surg 2012; 36:894.
  13. Valente DS, Zanella RK, Doncatto LF, Padoin AV. Incidence and risk factors of Striae Distensae following breast augmentation surgery: a cohort study. PLoS One 2014; 9:e97493.
  14. Kasielska-Trojan A, Sobczak M, Antoszewski B. Risk factors of striae gravidarum. Int J Cosmet Sci 2015; 37:236.
  15. Picard D, Sellier S, Houivet E, et al. Incidence and risk factors for striae gravidarum. J Am Acad Dermatol 2015; 73:699.
  16. Murphy KW, Dunphy B, O'Herlihy C. Increased maternal age protects against striae gravidarum. J Obstet Gynaecol 1992; 12:297.
  17. Kelekci KH, Kelekci S, Destegul E, et al. Prematurity: is it a risk factor for striae distensae? Int J Dermatol 2011; 50:1240.
  18. Mitts TF, Jimenez F, Hinek A. Skin biopsy analysis reveals predisposition to stretch mark formation. Aesthet Surg J 2005; 25:593.
  19. Lee KS, Rho YJ, Jang SI, et al. Decreased expression of collagen and fibronectin genes in striae distensae tissue. Clin Exp Dermatol 1994; 19:285.
  20. Wang F, Calderone K, Smith NR, et al. Marked disruption and aberrant regulation of elastic fibres in early striae gravidarum. Br J Dermatol 2015; 173:1420.
  21. Cordeiro RC, Zecchin KG, de Moraes AM. Expression of estrogen, androgen, and glucocorticoid receptors in recent striae distensae. Int J Dermatol 2010; 49:30.
  22. Klehr N. Striae cutis atrophicae. Morphokinetic examinations in vitro. Acta Derm Venereol Suppl (Stockh) 1979; 59:105.
  23. Simmons PS, Miles JM, Gerich JE, Haymond MW. Increased proteolysis. An effect of increases in plasma cortisol within the physiologic range. J Clin Invest 1984; 73:412.
  24. Lurie S, Matas Z, Fux A, et al. Association of serum relaxin with striae gravidarum in pregnant women. Arch Gynecol Obstet 2011; 283:219.
  25. Goldman A, Rossato F, Prati C. Stretch marks: treatment using the 1,064-nm Nd:YAG laser. Dermatol Surg 2008; 34:686.
  26. Hermanns JF, Piérard GE. High-resolution epiluminescence colorimetry of striae distensae. J Eur Acad Dermatol Venereol 2006; 20:282.
  27. Ono T, Matsunaga W, Yoshimura K. Striae distensae after tension-requiring skin sutures. J Dermatol 1991; 18:47.
  28. Al-Himdani S, Ud-Din S, Gilmore S, Bayat A. Striae distensae: a comprehensive review and evidence-based evaluation of prophylaxis and treatment. Br J Dermatol 2014; 170:527.
  29. Sheu HM, Yu HS, Chang CH. Mast cell degranulation and elastolysis in the early stage of striae distensae. J Cutan Pathol 1991; 18:410.
  30. Tsuji T, Sawabe M. Elastic fibers in striae distensae. J Cutan Pathol 1988; 15:215.
  31. Watson RE, Parry EJ, Humphries JD, et al. Fibrillin microfibrils are reduced in skin exhibiting striae distensae. Br J Dermatol 1998; 138:931.
  32. Zheng P, Lavker RM, Kligman AM. Anatomy of striae. Br J Dermatol 1985; 112:185.
  33. Piérard GE, Nizet JL, Adant JP, et al. Tensile properties of relaxed excised skin exhibiting striae distensae. J Med Eng Technol 1999; 23:69.
  34. Pui JC, Arroyo M, Heintz P. Linear focal elastosis: histopathologic diagnosis of an uncommon dermal elastosis. J Drugs Dermatol 2003; 2:79.
  35. Hashimoto K. Linear focal elastosis: Keloidal repair of striae distensae. J Am Acad Dermatol 1998; 39:309.
  36. Jeong JS, Lee JY, Kim MK, Yoon TY. Linear focal elastosis following striae distensae: further evidence of keloidal repair process in the pathogenesis of linear focal elastosis. Ann Dermatol 2011; 23:S141.
  37. Kineston DP, Xia Y, Turiansky GW. Anetoderma: a case report and review of the literature. Cutis 2008; 81:501.
  38. McDaniel DH, Ash K, Zukowski M. Treatment of stretch marks with the 585-nm flashlamp-pumped pulsed dye laser. Dermatol Surg 1996; 22:332.
  39. Shokeir H, El Bedewi A, Sayed S, El Khalafawy G. Efficacy of pulsed dye laser versus intense pulsed light in the treatment of striae distensae. Dermatol Surg 2014; 40:632.
  40. Alster TS. Laser treatment of hypertrophic scars, keloids, and striae. Dermatol Clin 1997; 15:419.
  41. Nehal KS, Lichtenstein DA, Kamino H, et al. Treatment of mature striae with the pulsed dye laser. J Cutan Laser Ther 1999; 1:41.
  42. Nouri K, Romagosa R, Chartier T, et al. Comparison of the 585 nm pulse dye laser and the short pulsed CO2 laser in the treatment of striae distensae in skin types IV and VI. Dermatol Surg 1999; 25:368.
  43. Jiménez GP, Flores F, Berman B, Gunja-Smith Z. Treatment of striae rubra and striae alba with the 585-nm pulsed-dye laser. Dermatol Surg 2003; 29:362.
  44. Yang YJ, Lee GY. Treatment of Striae Distensae with Nonablative Fractional Laser versus Ablative CO(2) Fractional Laser: A Randomized Controlled Trial. Ann Dermatol 2011; 23:481.
  45. Kim BJ, Lee DH, Kim MN, et al. Fractional photothermolysis for the treatment of striae distensae in Asian skin. Am J Clin Dermatol 2008; 9:33.
  46. Bak H, Kim BJ, Lee WJ, et al. Treatment of striae distensae with fractional photothermolysis. Dermatol Surg 2009; 35:1215.
  47. de Angelis F, Kolesnikova L, Renato F, Liguori G. Fractional nonablative 1540-nm laser treatment of striae distensae in Fitzpatrick skin types II to IV: clinical and histological results. Aesthet Surg J 2011; 31:411.
  48. Stotland M, Chapas AM, Brightman L, et al. The safety and efficacy of fractional photothermolysis for the correction of striae distensae. J Drugs Dermatol 2008; 7:857.
  49. Graber EM, Tanzi EL, Alster TS. Side effects and complications of fractional laser photothermolysis: experience with 961 treatments. Dermatol Surg 2008; 34:301.
  50. Tretti Clementoni M, Lavagno R. A novel 1565 nm non-ablative fractional device for stretch marks: A preliminary report. J Cosmet Laser Ther 2015; 17:148.
  51. Katz TM, Goldberg LH, Friedman PM. Nonablative fractional photothermolysis for the treatment of striae rubra. Dermatol Surg 2009; 35:1430.
  52. Malekzad F, Shakoei S, Ayatollahi A, Hejazi S. The Safety and Efficacy of the 1540nm Non-Ablative Fractional XD Probe of Star Lux 500 Device in the Treatment of Striae Alba: Before-After Study. J Lasers Med Sci 2014; 5:194.
  53. Guimarães PA, Haddad A, Sabino Neto M, et al. Striae distensae after breast augmentation: treatment using the nonablative fractionated 1550-nm erbium glass laser. Plast Reconstr Surg 2013; 131:636.
  54. Lee SE, Kim JH, Lee SJ, et al. Treatment of striae distensae using an ablative 10,600-nm carbon dioxide fractional laser: a retrospective review of 27 participants. Dermatol Surg 2010; 36:1683.
  55. Alexiades-Armenakas M, Sarnoff D, Gotkin R, Sadick N. Multi-center clinical study and review of fractional ablative CO2 laser resurfacing for the treatment of rhytides, photoaging, scars and striae. J Drugs Dermatol 2011; 10:352.
  56. Naeini FF, Nikyar Z, Mokhtari F, Bahrami A. Comparison of the fractional CO2 laser and the combined use of a pulsed dye laser with fractional CO2 laser in striae alba treatment. Adv Biomed Res 2014; 3:184.
  57. Savas JA, Ledon JA, Franca K, Nouri K. Lasers and lights for the treatment of striae distensae. Lasers Med Sci 2014; 29:1735.
  58. Metelitsa AI, Alster TS. Fractionated laser skin resurfacing treatment complications: a review. Dermatol Surg 2010; 36:299.
  59. Elson ML. Topical tretinoin in the treatment of striae distensae and in the promotion of wound healing: a review. J Dermatol Treat 1994; 5:163.
  60. Kang S, Kim KJ, Griffiths CE, et al. Topical tretinoin (retinoic acid) improves early stretch marks. Arch Dermatol 1996; 132:519.
  61. Rangel O, Arias I, García E, Lopez-Padilla S. Topical tretinoin 0.1% for pregnancy-related abdominal striae: an open-label, multicenter, prospective study. Adv Ther 2001; 18:181.
  62. Hexsel D, Soirefmann M, Porto MD, et al. Superficial dermabrasion versus topical tretinoin on early striae distensae: a randomized, pilot study. Dermatol Surg 2014; 40:537.
  63. Pribanich S, Simpson FG, Held B, et al. Low-dose tretinoin does not improve striae distensae: a double-blind, placebo-controlled study. Cutis 1994; 54:121.
  64. Elson ML. Treatment of striae distensae with topical tretinoin. J Dermatol Surg Oncol 1990; 16:267.
  65. Sarnoff DS. Therapeutic update on the treatment of striae distensae. J Drugs Dermatol 2015; 14:11.
  66. Goldberg DJ, Sarradet D, Hussain M. 308-nm Excimer laser treatment of mature hypopigmented striae. Dermatol Surg 2003; 29:596.
  67. Alexiades-Armenakas MR, Bernstein LJ, Friedman PM, Geronemus RG. The safety and efficacy of the 308-nm excimer laser for pigment correction of hypopigmented scars and striae alba. Arch Dermatol 2004; 140:955.
  68. Ostovari N, Saadat N, Nasiri S, et al. The 308-nm excimer laser in the darkening of the white lines of striae alba. J Dermatolog Treat 2010; 21:229.
  69. Sadick NS, Magro C, Hoenig A. Prospective clinical and histological study to evaluate the efficacy and safety of a targeted high-intensity narrow band UVB/UVA1 therapy for striae alba. J Cosmet Laser Ther 2007; 9:79.
  70. Ash K, Lord J, Zukowski M, McDaniel DH. Comparison of topical therapy for striae alba (20% glycolic acid/0.05% tretinoin versus 20% glycolic acid/10% L-ascorbic acid). Dermatol Surg 1998; 24:849.
  71. Adatto MA, Deprez P. Striae treated by a novel combination treatment--sand abrasion and a patent mixture containing 15% trichloracetic acid followed by 6-24 hrs of a patent cream under plastic occlusion. J Cosmet Dermatol 2003; 2:61.
  72. Kim SJ, Park JH, Kim DH, et al. Increased in vivo collagen synthesis and in vitro cell proliferative effect of glycolic acid. Dermatol Surg 1998; 24:1054.
  73. Mazzarello V, Farace F, Ena P, et al. A superficial texture analysis of 70% glycolic acid topical therapy and striae distensae. Plast Reconstr Surg 2012; 129:589e.
  74. Hernández-Pérez E, Colombo-Charrier E, Valencia-Ibiett E. Intense pulsed light in the treatment of striae distensae. Dermatol Surg 2002; 28:1124.
  75. Montesi G, Calvieri S, Balzani A, Gold MH. Bipolar radiofrequency in the treatment of dermatologic imperfections: clinicopathological and immunohistochemical aspects. J Drugs Dermatol 2007; 6:890.
  76. Manuskiatti W, Boonthaweeyuwat E, Varothai S. Treatment of striae distensae with a TriPollar radiofrequency device: a pilot study. J Dermatolog Treat 2009; 20:359.
  77. Suh DH, Chang KY, Son HC, et al. Radiofrequency and 585-nm pulsed dye laser treatment of striae distensae: a report of 37 Asian patients. Dermatol Surg 2007; 33:29.
  78. Dover JS, Rothaus K, Gold MH. Evaluation of safety and patient subjective efficacy of using radiofrequency and pulsed magnetic fields for the treatment of striae (stretch marks). J Clin Aesthet Dermatol 2014; 7:30.
  79. Kim IS, Park KY, Kim BJ, et al. Efficacy of intradermal radiofrequency combined with autologous platelet-rich plasma in striae distensae: a pilot study. Int J Dermatol 2012; 51:1253.
  80. Suh DH, Lee SJ, Lee JH, et al. Treatment of striae distensae combined enhanced penetration platelet-rich plasma and ultrasound after plasma fractional radiofrequency. J Cosmet Laser Ther 2012; 14:272.
  81. Ryu HW, Kim SA, Jung HR, et al. Clinical improvement of striae distensae in Korean patients using a combination of fractionated microneedle radiofrequency and fractional carbon dioxide laser. Dermatol Surg 2013; 39:1452.
  82. Goldberg DJ, Samady JA. Intense pulsed light and Nd:YAG laser non-ablative treatment of facial rhytids. Lasers Surg Med 2001; 28:141.
  83. Lipper GM, Perez M. Nonablative acne scar reduction after a series of treatments with a short-pulsed 1,064-nm neodymium:YAG laser. Dermatol Surg 2006; 32:998.
  84. Tay YK, Kwok C, Tan E. Non-ablative 1,450-nm diode laser treatment of striae distensae. Lasers Surg Med 2006; 38:196.
  85. Ud-Din S, McAnelly SL, Bowring A, et al. A double-blind controlled clinical trial assessing the effect of topical gels on striae distensae (stretch marks): a non-invasive imaging, morphological and immunohistochemical study. Arch Dermatol Res 2013; 305:603.
  86. Shin JU, Roh MR, Rah DK, et al. The effect of succinylated atelocollagen and ablative fractional resurfacing laser on striae distensae. J Dermatolog Treat 2011; 22:113.
  87. Draelos ZD, Gold MH, Kaur M, et al. Evaluation of an onion extract, Centella asiatica, and hyaluronic acid cream in the appearance of striae rubra. Skinmed 2010; 8:80.
  88. Brennan M, Young G, Devane D. Topical preparations for preventing stretch marks in pregnancy. Cochrane Database Syst Rev 2012; 11:CD000066.
  89. Korgavkar K, Wang F. Stretch marks during pregnancy: a review of topical prevention. Br J Dermatol 2015; 172:606.
  90. Soltanipour F, Delaram M, Taavoni S, Haghani H. The effect of olive oil and the Saj® cream in prevention of striae gravidarum: A randomized controlled clinical trial. Complement Ther Med 2014; 22:220.